Abstract:The aim of the study is to assess the effectiveness of 14-days course of Clarithromycin-based triple therapy as first line therapy for H. pylori infection in Egyptian elderly patients with normal liver and kidney functions. Methods: The study was experimental study carried out on 34 elderly patients having H. pylori gastritis with normal liver and kidney functions. We tested for H. pylori stool antigen using a quantitative monoclonal enzyme-linked immunosorbent assay (ELISA) assay before and 4 weeks after the treatment to confirm eradication. Patients received Clarithromycin-based triple therapy (Clarithromycin 500mg twice daily, Amoxicillin 1000mg twice daily, and Omeprazole 40mg twice daily) for H. pylori eradication for 14 days. Results: The cure rate of Clarithromycinbased triple therapy was 88.2% (30/34) and only 11.8% (4/34) was having persistent infection. None of the patients discontinued the drugs indicating good tolerability .Conclusion: The use of 14-days course of Clarithromycin-based triple therapy as first line therapy for H. pylori infection is highly effective and tolerable in Egyptian elderly patients with normal liver and kidney functions.
Introduction
Helicobacter pylori (H. pylori) are Gramnegative bacteria, belonging to a separate group of Helicobacter species. It contains a hydrogenase, used to obtain energy by oxidizing molecular hydrogen (H2) produced by intestinal bacteria [1] . It produces oxidase, catalase, and urease [2] . The most common routes of H. pylori infection are fecal-to-oral, oral-tooral, or gastro/oral exposure. Humans appear to be the major reservoir of infection [3] .
H. pylori is the most common chronic bacterial infection in humans. At least 50% of all people are infected [4] . The prevalence of Helicobacter pylori infection increases with age and may affect 75% of elderly patients [5] .
There are many virulence factors of H. pylori that may be responsible for the pathogenesis of H. pylori related diseases such as ammonia, CAG-A (cytotoxinassociated gene A) and VAC [13] .
The Faecal Antigen Test (FAT) can be used interchangeably with the urea breath testing (UBT) to identify H. pylori before antibiotic therapy [14] . The FAT has been approved by the U.S. Food and Drug Administration and supported by the European "Maastricht2-2000 Consensus Report" as an alternative to UBT in establishing the cure of H. pylori infection [15] . Recent studies indicate that the FAT may be effective in confirming eradication as early as 14 days after treatment [16, 17] Confirmation should be performed at least 4weeks after eradication therapy has been completed [14] .
The resistances of H. pylori to antibiotics may be particularly relevant in elderly patients for two reasons. First, the prevalence of drug consumption including antibiotics is higher in this population. Second, the compliance in elderly population is lower than younger population [20, 21] .
The aims of the current study were to:
 Assess the use of Clarithromycinbased triple therapy as a first line therapy in Egyptian elderly patients with normal liver and kidney functions.
 Estimate the resistance rate of this therapy.
 Assess the compliance of our elderly patients on this regimen.
Subjects and Methods
This study was carried out on Egyptian non-hepatic non-renal elderly patients (65 years or older) having Helicobacter pylori gastritis attending the geriatric clinic in Faculty of Medicine, Alexandria University at year 2013. There were 34 patients who met the criteria for the study Inclusion Criteria:
 The patient did not receive H.pylori eradication therapy before.
Exclusion Criteria:
 Abnormal liver function tests.
 Abnormal renal function tests.
 Patients with history of PPI intake within the past 2 weeks.
 Patients with history of antibiotic intake within the past 4 weeks.
The study was accepted by the local ethical commity and each patient has full explanation about the study and informed consent was signed by each patient.
All patients included in the study were subjected to the following:
I. Thorough history taking.
II. Complete clinical examination.
III. Basic Laboratory investigations:
 Complete blood picture.
 Complete urine analysis.
 Complete stool analysis. fig.1) .
None of the patients discontinued the treatment regimen indicating good tolerability ( fig.2 ).
There was no statistical significant difference between the responders and the non-responders as regards the sex and the age (table1). [14] .
Discussion
Another regimen is the sequential therapy regimen which consists of standard dose PPI b.i.d. and amoxicillin 1 g b.i.d. followed for 5 days followed by standard dose PPI b.i.d., Clarithromycin 500 mg, and Tinidazole 500 mg b.i.d. for 5 days. This regimen achieved ˃90% eradication rate. In the available studies, the reported compliance with therapy has exceeded 90% and side effects have been no greater than those experienced with Clarithromycin triple therapy. But the compliance may be lower in elderly patients. In addition, it is not clear that there is any incremental benefit to providing antibiotic therapy sequentially rather than as a concurrent quadruple regimen. So, further studies are needed to consider this regimen as first line therapy and to compare it with other regimens especially in the elderly patients [14] .
So in the current study, Clarithromycinbased triple therapy for 14 days was used as first line therapy for H. pylori infected elderly patients. The regimen has achieved a cure rate of 88% which is slightly better than the recorded cure rate for this regimen. The American College of Gastroenterology Guideline on the Management of H. pylori Infection 2007 stated that this regimen can achieve a cure rate up to 85% [14] .
In elderly patients, either 14-days course or 7-days course can be used. A recent metaanalysis of seven studies including more than 900 patients found that a 14-day course of Clarithromycin triple therapy provided better eradication rates than a 7-day course of therapy [24] .
In the current study, a twice daily dosing of PPI was used instead of once daily dosing because data from a recent meta-analysis of 13 studies suggested that twice daily dosing of a PPI in Clarithromycin-based triple regimens is more effective than once daily dosing [25] .
Helicobacter pylori resistance is an important factor involved in the failure of treatment. Tables and Graphs 
